Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pregnant women needed: could extra vitamin d stop asthma before it starts?

NCT ID NCT06570889

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study is testing whether taking a higher dose of vitamin D (2400 IU daily) during pregnancy can prevent asthma and persistent wheezing in children up to age 3. Researchers plan to enroll 2000 pregnant women in Denmark. Participants take either vitamin D or a placebo capsule from week 22-26 of pregnancy until one week after giving birth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Copenhagen University Hospital of Copenhagen

    RECRUITING

    Gentofte Municipality, DK-2820, Denmark

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Vitamin D (cholecalciferol D3)

What this could lead to

If it works, this could point toward a simple, low-cost way to reduce the risk of asthma in young children by giving higher doses of vitamin D during pregnancy.

What could go wrong

This is a large phase 3 trial, but it is still possible that the supplement will not reduce asthma risk. The study only includes pregnant women with specific fatty acid levels, so results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

allergic disease asthma bone fracture croup Eczema Infections psychiatric disorder Respiratory Sounds respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.